acarbose
Patients treated with       acarbose were significantly more likely to undergo a dose reduction in       concomitant diabetic treatments compared with the control group; they were also       less likely to require an increase in the dose of standard treatment and to start       insulin during the study period.
 @OBJECT$   @PREDICAT$  with        @SUBJECT$  were significantly more likely to undergo a dose reduction in       concomitant diabetic treatments compared with the control group; they were also       less likely to require an increase in the dose of standard treatment and to start       insulin during the study period.